These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32970896)

  • 21. Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.
    Shaked O; Demetris J; Levitsky J; Feng S; Loza BL; Punch J; Reyes J; Klintmalm G; Jackson W; DesMarais M; Sayre P; Shaked A; Reddy KR
    Transplantation; 2022 Jan; 106(1):106-116. PubMed ID: 33982909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic Steatosis Is Prevalent Following Orthotopic Liver Transplantation in Children With Cystic Fibrosis.
    Cortes-Santiago N; Leung DH; Castro E; Finegold M; Wu H; Patel KR
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):96-103. PubMed ID: 30234762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications.
    John BV; Aiken T; Garber A; Thomas D; Lopez R; Patil D; Konjeti VR; Fung JJ; McCollough AJ; Askar M
    Exp Clin Transplant; 2018 Aug; 16(4):439-445. PubMed ID: 29863454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
    Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
    Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.
    Kleiner DE; Makhlouf HR
    Clin Liver Dis; 2016 May; 20(2):293-312. PubMed ID: 27063270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steatosis in donor and transplant liver biopsies.
    Crowley H; Lewis WD; Gordon F; Jenkins R; Khettry U
    Hum Pathol; 2000 Oct; 31(10):1209-13. PubMed ID: 11070113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.
    Pais R; Charlotte F; Fedchuk L; Bedossa P; Lebray P; Poynard T; Ratziu V;
    J Hepatol; 2013 Sep; 59(3):550-6. PubMed ID: 23665288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causes of secondary non-alcoholic fatty liver disease in non-obese children below 10 years.
    Mogahed EA; Sayed AA; Khalifa SE; El-Hennawy A; El-Raziky MS
    Eur J Pediatr; 2020 May; 179(5):719-726. PubMed ID: 31897838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.
    Idowu MO; Chhatrala R; Siddiqui MB; Driscoll C; Stravitz RT; Sanyal AJ; Bhati C; Sargeant C; Luketic VA; Sterling RK; Contos M; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 Nov; 21(11):1395-402. PubMed ID: 26228654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation.
    Garcia RF; Morales E; Garcia CE; Saksena S; Hübscher SG; Elias E
    Arq Gastroenterol; 2001; 38(4):247-53. PubMed ID: 12068535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
    Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
    J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis.
    Sugimoto K; Moriyasu F; Oshiro H; Takeuchi H; Abe M; Yoshimasu Y; Kasai Y; Sakamaki K; Hara T; Itoi T
    Radiology; 2020 Sep; 296(3):532-540. PubMed ID: 32573385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival.
    Northup PG; Intagliata NM; Davis JPE; Argo CK; Pelletier SJ
    Transplantation; 2020 Jun; 104(6):1193-1200. PubMed ID: 31577675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive markers of liver steatosis and fibrosis after liver transplantation - Where do we stand?
    Mikolasevic I; Stojsavljevic S; Blazic F; Mijic M; Radic-Kristo D; Juric T; Skenderevic N; Klapan M; Lukic A; Filipec Kanizaj T
    World J Transplant; 2021 Mar; 11(3):37-53. PubMed ID: 33816145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Brown GT; Kleiner DE
    Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics].
    Anisonyan AV; Sandler YG; Khaimenova TY; Keyan VA; Saliev KG; Sbikina ES; Vinnitskaya EV
    Ter Arkh; 2020 Sep; 92(8):73-78. PubMed ID: 33346465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.